{"id":"W4221085387","doi":"10.1101/2022.03.10.22271799","title":"Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer","year":2022,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Foghorn Therapeutics; Gilead Sciences; National Cancer Institute; Genentech; Janssen Research and Development; National Institutes of Health; Sierra Oncology; V Foundation for Cancer Research; Astellas Pharma; Eisai; Prostate Cancer UK; National Institute for Health and Care Research; MacroGenics; DOD Prostate Cancer Research Program; Vertex Pharmaceuticals; Bristol-Myers Squibb; AstraZeneca; Movember Foundation; Sanofi; Pfizer; Wellcome Trust; Cancer Research UK; Doris Duke Charitable Foundation; U.S. Department of Veterans Affairs","keywords":"Prostate cancer; Androgen receptor; Biomarker; Androgen deprivation therapy; Immunohistochemistry; Oncology; Medicine; Cancer research; Prostate; splice; Internal medicine; Androgen; Messenger RNA; Cancer; Biology; Hormone; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001392708,0.0002691751,0.000466925,0.0009349915,0.0002407369,0.001025209,0.0004130406,0.0004084737,0.001234061],"category_scores_gemma":[0.001445712,0.0001199252,0.0004033829,0.0007917333,0.0003068972,0.0001988869,0.0003505888,0.0005512693,0.0003605694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00045565,"about_ca_system_score_gemma":0.0003291806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001722944,"about_ca_topic_score_gemma":0.00344929,"domain_scores_codex":[0.9990591,0.000223232,0.00007072953,0.0002445416,0.000318752,0.00008363833],"domain_scores_gemma":[0.9984509,0.0004057853,0.0003889247,0.0001700913,0.0004242295,0.0001600707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001997621,0.0002445798,0.7730023,0.0005417367,0.0008565584,0.0002756966,0.0002198614,0.002691175,0.1812836,0.0004940162,0.002380565,0.03601234],"study_design_scores_gemma":[0.00004817111,0.001200812,0.9007201,0.0000781913,0.0004257324,0.001317394,0.0003601837,0.007586762,0.08115776,0.000788691,0.006260962,0.00005522883],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887755,0.00320254,0.002379622,0.0001610439,0.00004742278,0.00004154758,0.00390043,0.0001765573,0.001315458],"genre_scores_gemma":[0.9939548,0.0003394806,0.001322885,0.0001229923,0.00002418887,0.00002746506,0.003781462,0.00002662032,0.0004000356],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001722944,"threshold_uncertainty_score":0.007365406,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08524871362891821,"score_gpt":0.4586015234323757,"score_spread":0.3733528098034575,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}